Class Action Lawsuit Announced by Bragar Eagel & Squire, P.C.

Squire, P.C., a well-known legal firm specializing in stockholder rights, has recently announced the filing of a class action lawsuit against PomDoctor, Ltd. on behalf of investors who suffered losses due to the company’s actions. The lawsuit was filed in the United States District Court for the Southern District of New York. The alleged misconduct occurred between October 9, 2025, and December 11, 2025, spanning a period of significant stock trading activity.

According to the complaint, the defendants, including PomDoctor, engaged in fraudulent activities that misled investors about the company’s true financial standing and business operations. It is claimed that PomDoctor was involved in a deceptive stock promotion scheme spread through social media and impersonated financial professionals. Additionally, insiders and affiliates were accused of using offshore accounts to artificially inflate the stock price and then profit from the ensuing price surge. These actions were allegedly concealed from investors, leading them to make misinformed decisions based on inaccurate or incomplete information.

The lawsuit asserts that PomDoctor’s public statements and disclosures failed to address the false information circulating about the company and the manipulation of its stock price. As a result, investors were misled into believing the company’s business and prospects were more favorable than they actually were. The lawsuit aims to hold the defendants accountable for the alleged securities fraud and seeks to recover losses suffered by investors during the class period.

Investors who purchased or acquired PomDoctor securities during the specified period and experienced financial losses as a result may be eligible to participate in the class action lawsuit. They are encouraged to reach out to Bragar Eagel & Squire, P.C. to discuss their legal rights and explore their options. The firm’s Litigation Partner, Brandon Walker, and Melissa Fortunato are available to provide assistance and guidance to affected investors who wish to learn more about the case.

Individuals with relevant information, long-term shareholders of PomDoctor, or those interested in understanding the allegations against the company are encouraged to contact the legal team for further details. There is no financial obligation for reaching out, and investors can seek clarification on their rights and involvement in the lawsuit. Bragar Eagel & Squire, P.C. is committed to representing the interests of both individual and institutional investors in cases of securities fraud, derivative issues, and commercial litigation.

For more information about the legal firm or to stay updated on the latest developments in the case against PomDoctor, investors can visit the firm’s official website. The legal team at Bragar Eagel & Squire, P.C. aims to provide comprehensive support to investors seeking redress for their losses and to pursue justice against alleged securities violations in the market.